Co-culture assays and multiplex immunohistochemistry (mIHC) were used to assess TME remodeling.<h4>Results</h4>Elevated CALB2 expression correlated significantly with poor prognosis in CRC patients. The gene discussed is CALB2; the disease is colorectal carcinoma.